📖 Approx. 8 minutes
What is a Transition to a Non-Proprietary Medical Corporation?
Medical corporations are broadly categorized into two types: “proprietary medical corporations” that pursue the profits of their shareholders, and “non-proprietary medical corporations” that aim for social contribution. Due to the 2007 amendment of the Medical Care Act, new establishments are generally unified into non-proprietary medical corporations. However, existing proprietary medical corporations that meet certain requirements can transition to non-proprietary medical corporations. This transition can be an important option for many medical corporations, considering future business succession and the survival and development of medical institutions. This article explains the advantages, disadvantages, tax considerations, and specific steps for transitioning to a non-proprietary medical corporation from a professional perspective, aimed at directors of medical corporations and clinic presidents considering such a transition.
Advantages of Transitioning to a Non-Proprietary Medical Corporation
Transitioning to a non-proprietary medical corporation not only eliminates shareholder equity but also brings various benefits in terms of organizational management and taxation. In particular, by clarifying its non-profit nature, it becomes easier to further pursue the original objective of contributing to regional healthcare. It is also effective in establishing a foundation for smooth future business succession. Specific advantages include:
- Clarification of Non-Profit Status and Enhanced Governance: With no equity, the organization can shift its focus from pursuing the personal interests of shareholders to its original objectives, such as improving the quality of medical care and contributing to the community. The authority of the general meeting of members is strengthened, leading to expectations of a more democratic and transparent decision-making process.
- Realization of Smooth Business Succession: In proprietary medical corporations, the transfer of equity due to inheritance or gift often involved complex procedures and high tax burdens. Transitioning to a non-proprietary medical corporation resolves these issues, enabling a smoother succession to the next generation.
- Reduction of Future Tax Burden: Non-proprietary medical corporations do not incur inheritance or gift taxes on shareholder equity. Furthermore, if certain requirements are met, residual assets upon dissolution can be attributed to other medical corporations, potentially reducing the corporate tax burden.
- Improved Social Credibility: As the status as a non-profit and highly public-interest organization becomes clear, it becomes easier to gain trust from administrative bodies and the local community. This can lead to the utilization of subsidies and grants, and the strengthening of regional cooperation.
To enjoy these benefits, it is essential to clarify the purpose of the transition and engage in careful planning and collaboration with experts.
Disadvantages and Considerations for Transitioning to a Non-Proprietary Medical Corporation
While transitioning to a non-proprietary medical corporation offers many advantages, there are also disadvantages and points to consider. It is particularly important to fully understand the procedures involved and the changes in organizational management beforehand.
- Elimination of Shareholder Equity: Upon transition, shareholder equity is extinguished. This means the loss of economic returns for shareholders. Therefore, sufficient understanding and consensus among all shareholders are essential when making the decision to transition.
- Complexity of Transition Procedures: The transition to a non-proprietary medical corporation involves cumbersome procedures such as applying for approval from the competent authority and amending the articles of incorporation. As specialized knowledge is required, support from experts such as administrative scriveners, tax accountants, and M&A consultants is often indispensable.
- Necessity of Fund Contribution: In non-proprietary medical corporations, it is common to establish a “fund” in place of shareholder equity. This fund is considered the corporation’s capital and is not subject to repayment upon dissolution. A fund contribution is required at the time of transition, and the amount and method of contribution must be carefully considered based on the individual circumstances.
- Adaptation to Changes in Organizational Management: In non-proprietary medical corporations, the organizational management structure changes, such as the strengthening of the general meeting of members’ authority. Directors and board members must adapt to these changes and strive for more transparent operations.
Based on these disadvantages and considerations, it is important to proceed cautiously only when the benefits of the transition are deemed to outweigh the disadvantages.
Tax Issues in Transitioning to a Non-Proprietary Medical Corporation
The transition to a non-proprietary medical corporation involves several important tax issues. In particular, specialized knowledge is essential regarding the valuation of shareholder equity and the tax implications of the transition.
Valuation and Taxation of Shareholder Equity
When transitioning from a proprietary medical corporation to a non-proprietary one, gift tax or income tax may be levied at the time of transition, depending on the valuation of shareholder equity. Generally, the valuation of shareholder equity considers the net assets of the medical corporation and its future profitability, but the calculation method requires specialized knowledge. In particular, when equity is valued and transferred as part of inheritance tax planning, tax risks must be thoroughly examined.
Fund Contribution and Taxation
The tax treatment of the fund contribution required for the transition to a non-proprietary medical corporation also needs to be confirmed. The contributed fund is treated as the capital of the medical corporation and is generally not subject to corporate tax. However, upon repayment of the fund, the contributor may be subject to income tax as miscellaneous income or lump-sum income. The medical corporation also needs to establish regulations regarding the management and repayment of the fund.
Utilization of Business Succession Tax System
The transition to a non-proprietary medical corporation is made with future business succession in mind. If certain requirements are met, the utilization of the business succession tax system (tax deferral system) for small and medium-sized enterprises may be considered. This system can significantly reduce the burden of inheritance and gift taxes. However, the business succession tax system applicable to medical corporations has specific requirements and procedures, making consultation with experts indispensable.
【Summary of Tax Considerations】
- Consideration of the valuation method for shareholder equity and the associated gift and income tax risks.
- Confirmation of the tax treatment of fund contributions and the possibility of future income tax upon repayment.
- Examination of the applicability of the business succession tax system (tax deferral system) and its associated requirements and procedures.
- Confirmation of the tax treatment for the medical corporation after the transition (corporate tax, consumption tax, business tax, etc.).
These tax issues vary significantly depending on the specific circumstances of each medical corporation. Always consult with experts such as tax accountants and M&A consultants.
Steps Towards Transitioning to a Non-Proprietary Medical Corporation
It is important to proceed with the transition to a non-proprietary medical corporation in a planned and phased manner. The following outlines the general steps for transition. However, procedures and timelines may vary depending on individual circumstances.
- Current Situation Analysis and Clarification of Transition Objectives: First, conduct a detailed analysis of the current organizational structure, financial status, and shareholder intentions of the medical corporation. Then, clarify the objective of transitioning to a non-proprietary medical corporation (e.g., facilitating business succession, strengthening non-profit status, contributing to regional healthcare).
- Formation of an Expert Team: The transition requires extensive expertise in medical law, taxation, and legal affairs. Appoint reliable experts such as lawyers, tax accountants, administrative scriveners, and M&A consultants to form a team.
- Development of a Transition Plan: In collaboration with the expert team, develop a detailed transition plan that includes the transition schedule, specific procedures, the amount and method of fund contribution, and matters for resolution by the general meeting of members.
- Resolution at the General Meeting of Members: Obtain approval for the developed transition plan at the general meeting of members (shareholder meeting). It is crucial to fully explain the advantages, disadvantages, and tax implications of the transition and achieve consensus among all shareholders.
- Application for Approval from the Competent Authority: After approval at the general meeting of members, apply for approval to transition to a non-proprietary medical corporation from the competent authority (e.g., prefectural governor). Prepare necessary documents and proceed with the application process in cooperation with experts.
- Amendment of Articles of Incorporation and Registration: After approval is granted, amend the articles of incorporation and, if necessary, complete the registration.
- Establishment of Post-Transition Operational Structure: After the transition is complete, commence operations based on the new organizational structure. Promote initiatives to achieve the transition objectives, such as strengthening the governance system and enhancing cooperation with the local community.
【Key Points in the Transition Process】
- Information Disclosure and Consensus Building: Sufficient information disclosure and careful consensus building with stakeholders such as shareholders, directors, and staff are essential.
- Collaboration with Experts: Seek advice from experts at each stage to minimize legal, tax, and administrative risks.
- Flexible Response: Be prepared for the possibility that the plan may not proceed as expected and respond flexibly according to the situation.
These steps are a general guideline and need to be customized according to the circumstances of each medical corporation. M&A Medical provides comprehensive support from the development of the optimal transition plan to its execution, based on a detailed hearing of the medical corporation’s situation.
For Medical Institution M&A and Business Succession, Consult M&A Medical
The medical corporation system is constantly changing due to social conditions and legal amendments. Transitioning to a non-proprietary medical corporation can be an effective option for many medical corporations from the perspective of future business succession and contribution to regional healthcare. However, the procedures are complex, and there are many tax-related issues. M&A Medical (CentralMedience Inc.), as an M&A support institution certified by the Small and Medium Enterprise Agency, has a team of experts specializing in M&A and business succession in the medical industry. We will carefully listen to your institution’s situation and propose optimal solutions from legal, tax, and financial perspectives. We offer meticulous support for all management challenges of medical institutions, including consultations on transitioning to non-proprietary medical corporations, business expansion through M&A, and considering closure due to lack of successors. Please feel free to contact us for an initial consultation.
Consult M&A Medical for Medical Succession
M&A Medical is a specialized M&A and business succession support service for medical institutions. As an M&A support institution certified by the Small and Medium Enterprise Agency, we support the success of transfers from clinics and medical corporations struggling with successor shortages to strategic acquisitions on a success-fee basis.
- Initial consultation and preliminary assessment are free
- No upfront fees or monthly charges (success fee only)
- Strict confidentiality (proceeding under NDA)
- Service available nationwide in all 47 prefectures and for all medical specialties
Please consult us early, even if you only want to know the market value, have no successor, or are considering joining a group. We are here to help.